Measurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journey

Maximilian Stahl; Martin S. Tallman; Aaron D. Goldberg

doi:10.1080/10428194.2021.1929967

Measurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journey

Maximilian Stahl^*, Martin S. Tallman, Aaron D. Goldberg

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2050-2051
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	62
Issue number	9
DOIs	https://doi.org/10.1080/10428194.2021.1929967
State	Published - 2021

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2021.1929967

Cite this

@article{cfa290c921f442afbecb9090e0723f9c,

title = "Measurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journey",

author = "Maximilian Stahl and Tallman, {Martin S.} and Goldberg, {Aaron D.}",

year = "2021",

doi = "10.1080/10428194.2021.1929967",

language = "English (US)",

volume = "62",

pages = "2050--2051",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "9",

}

TY - JOUR

T1 - Measurable residual disease negativity in acute myeloid leukemia

T2 - the destination may matter more than the journey

AU - Stahl, Maximilian

AU - Tallman, Martin S.

AU - Goldberg, Aaron D.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85115087570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115087570&partnerID=8YFLogxK

U2 - 10.1080/10428194.2021.1929967

DO - 10.1080/10428194.2021.1929967

M3 - Comment/debate

C2 - 34519611

AN - SCOPUS:85115087570

SN - 1042-8194

VL - 62

SP - 2050

EP - 2051

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 9

ER -

Measurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journey

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this